-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Prime Medicine, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to Q3 2025.
- Prime Medicine, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$50.6M, a 3.69% increase year-over-year.
- Prime Medicine, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$197M, a 9.99% increase year-over-year.
- Prime Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$196M, a 1.14% increase from 2023.
- Prime Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$198M, a 62.6% decline from 2022.
- Prime Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$122M, a 26.3% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)